Logo image of POET

POET TECHNOLOGIES INC (POET) Stock Fundamental Analysis

NASDAQ:POET - Nasdaq - CA73044W3021 - Common Stock - Currency: USD

4.4  -0.32 (-6.78%)

After market: 4.5184 +0.12 (+2.69%)

Fundamental Rating

2

Overall POET gets a fundamental rating of 2 out of 10. We evaluated POET against 107 industry peers in the Semiconductors & Semiconductor Equipment industry. The financial health of POET is average, but there are quite some concerns on its profitability. POET has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year POET has reported negative net income.
POET had a negative operating cash flow in the past year.
POET had negative earnings in each of the past 5 years.
POET had a negative operating cash flow in each of the past 5 years.
POET Yearly Net Income VS EBIT VS OCF VS FCFPOET Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -63.17%, POET is doing worse than 90.74% of the companies in the same industry.
POET has a Return On Equity of -104.21%. This is amonst the worse of the industry: POET underperforms 84.26% of its industry peers.
Industry RankSector Rank
ROA -63.17%
ROE -104.21%
ROIC N/A
ROA(3y)-141.78%
ROA(5y)-121.23%
ROE(3y)-219.16%
ROE(5y)-200.3%
ROIC(3y)N/A
ROIC(5y)N/A
POET Yearly ROA, ROE, ROICPOET Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -100 -200 -300 -400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for POET so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
POET Yearly Profit, Operating, Gross MarginsPOET Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K

4

2. Health

2.1 Basic Checks

POET does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for POET has been increased compared to 1 year ago.
Compared to 5 years ago, POET has more shares outstanding
POET has a worse debt/assets ratio than last year.
POET Yearly Shares OutstandingPOET Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
POET Yearly Total Debt VS Total AssetsPOET Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

An Altman-Z score of 2.83 indicates that POET is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of POET (2.83) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.01 indicates that POET is not too dependend on debt financing.
POET's Debt to Equity ratio of 0.01 is fine compared to the rest of the industry. POET outperforms 65.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 2.83
ROIC/WACCN/A
WACC10.56%
POET Yearly LT Debt VS Equity VS FCFPOET Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M

2.3 Liquidity

A Current Ratio of 2.20 indicates that POET has no problem at all paying its short term obligations.
POET's Current ratio of 2.20 is on the low side compared to the rest of the industry. POET is outperformed by 71.30% of its industry peers.
A Quick Ratio of 2.20 indicates that POET has no problem at all paying its short term obligations.
POET has a Quick ratio of 2.20. This is comparable to the rest of the industry: POET outperforms 52.78% of its industry peers.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 2.2
POET Yearly Current Assets VS Current LiabilitesPOET Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

3

3. Growth

3.1 Past

POET shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.46%.
Looking at the last year, POET shows a very negative growth in Revenue. The Revenue has decreased by -78.58% in the last year.
EPS 1Y (TTM)-13.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
Revenue 1Y (TTM)-78.58%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, POET will show a very strong growth in Earnings Per Share. The EPS will grow by 21.19% on average per year.
Based on estimates for the next years, POET will show a very strong growth in Revenue. The Revenue will grow by 290.49% on average per year.
EPS Next Y12%
EPS Next 2Y23.29%
EPS Next 3Y21.19%
EPS Next 5YN/A
Revenue Next Year-88.34%
Revenue Next 2Y199.57%
Revenue Next 3Y312.9%
Revenue Next 5Y290.49%

3.3 Evolution

POET Yearly Revenue VS EstimatesPOET Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
POET Yearly EPS VS EstimatesPOET Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6

1

4. Valuation

4.1 Price/Earnings Ratio

POET reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for POET. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
POET Price Earnings VS Forward Price EarningsPOET Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
POET Per share dataPOET EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

A more expensive valuation may be justified as POET's earnings are expected to grow with 21.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.29%
EPS Next 3Y21.19%

0

5. Dividend

5.1 Amount

POET does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

POET TECHNOLOGIES INC

NASDAQ:POET (2/21/2025, 8:00:01 PM)

After market: 4.5184 +0.12 (+2.69%)

4.4

-0.32 (-6.78%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)03-13 2025-03-13/amc
Inst Owners7.22%
Inst Owner Change-66.37%
Ins Owners0.62%
Ins Owner ChangeN/A
Market Cap337.08M
Analysts82.5
Price Target5.87 (33.41%)
Short Float %4.99%
Short Ratio1.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-91.59%
Min EPS beat(2)-130.68%
Max EPS beat(2)-52.51%
EPS beat(4)0
Avg EPS beat(4)-52.91%
Min EPS beat(4)-130.68%
Max EPS beat(4)-10.83%
EPS beat(8)3
Avg EPS beat(8)-25.69%
EPS beat(12)5
Avg EPS beat(12)-17.32%
EPS beat(16)8
Avg EPS beat(16)-15.47%
Revenue beat(2)0
Avg Revenue beat(2)-96.73%
Min Revenue beat(2)-100%
Max Revenue beat(2)-93.46%
Revenue beat(4)1
Avg Revenue beat(4)-45.16%
Min Revenue beat(4)-100%
Max Revenue beat(4)111.77%
Revenue beat(8)1
Avg Revenue beat(8)-38.36%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.47%
PT rev (3m)16.51%
EPS NQ rev (1m)14.29%
EPS NQ rev (3m)40%
EPS NY rev (1m)-6.02%
EPS NY rev (3m)-6.02%
Revenue NQ rev (1m)50.02%
Revenue NQ rev (3m)-83.33%
Revenue NY rev (1m)16.28%
Revenue NY rev (3m)-56.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2810.2
P/FCF N/A
P/OCF N/A
P/B 11.01
P/tB 11.22
EV/EBITDA N/A
EPS(TTM)-0.59
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS0
BVpS0.4
TBVpS0.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -63.17%
ROE -104.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-141.78%
ROA(5y)-121.23%
ROE(3y)-219.16%
ROE(5y)-200.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 147.79%
Cap/Sales 2522.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.2
Quick Ratio 2.2
Altman-Z 2.83
F-Score3
WACC10.56%
ROIC/WACCN/A
Cap/Depr(3y)129.14%
Cap/Depr(5y)158.27%
Cap/Sales(3y)422.93%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
EPS Next Y12%
EPS Next 2Y23.29%
EPS Next 3Y21.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-78.58%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-88.34%
Revenue Next 2Y199.57%
Revenue Next 3Y312.9%
Revenue Next 5Y290.49%
EBIT growth 1Y-12.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year0.73%
EBIT Next 3Y8.78%
EBIT Next 5YN/A
FCF growth 1Y-42.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.98%
OCF growth 3YN/A
OCF growth 5YN/A